Question 1

Does Citadel Advisors own ACRS stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Citadel Advisors holds 1,762,081 shares of ACRS (Aclaris Therapeutics), worth $9.3M.

Question 2

How many shares of ACRS does Citadel Advisors own?

Accepted Answer

As of its Q2 2026 13F, Citadel Advisors holds 1,762,081 shares of ACRS (Aclaris Therapeutics).

Question 3

What is Citadel Advisors' ACRS position worth?

Accepted Answer

As of its Q2 2026 13F, Citadel Advisors' ACRS position is worth $9.3M.

Question 4

Is Citadel Advisors buying or selling ACRS?

Accepted Answer

In Q2 2026, Citadel Advisors reduced its ACRS position by 487,238 shares (-21.7%).

Question 5

When did Citadel Advisors first buy ACRS?

Accepted Answer

Citadel Advisors already held ACRS in its Q4 2018 13F, the earliest on record, and has listed it in 30 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	1.8M	-21.7%	$9.3M	0.0%	$5.29	0
2026-Q1	Increased	2.2M	+86.6%	$8.4M	0.0%	$3.75	43
2025-Q4	Decreased	1.2M	-15.9%	$3.6M	0.0%	$3.01	0
2025-Q3	Increased	1.4M	+25.3%	$2.7M	0.0%	$1.90	32
2025-Q2	Increased	1.1M	+1.9%	$1.6M	0.0%	$1.42	26
2025-Q1	Increased	1.1M	+1927.4%	$1.7M	0.0%	$1.53	41
2024-Q4	Decreased	55,347	-84.8%	$137,261	0.0%	$2.48	0
2024-Q3	Decreased	364,567	-58.4%	$419,252	0.0%	$1.15	0

ACRSShowing 8 of 31 quarters

ACRS
Showing 8 of 31 quarters